Request Call Back

Contact Us

Actos
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Actos Macular Edema

Actos Side Effects linked to Actos Macular Edema, Lawsuits
Download your Actos Information Package Actos Timeline: Side Effects, Liability, Warnings, and Litigations

Actos Macular Edema Lawyers

Actos (Pioglitazone Hydrochloride) Actos Side Effects May Include; Macular Edema, Bladder Cancer, Heart Attacks, Cardiovascular Heart Risks | FDA Warning: Diabetes Drug may Increase Bladder Cancer Risk | Actos Linked to Serious Health Issues

Actos Macular Edema Lawyers

Actos Macular Edema

Type 2 diabetics who use Actos (rosiglitazone) may be in danger of developing diabetic macular edema, a serious eye disorder that can result in vision loss. In June 2012, a study published in the Archives of Internal Medicine found that patients taking thiazolidinediones, a class of type 2 diabetes medications that includes Actos, were two to three times more likely to develop diabetes macular edema compared to patients not treated with the drugs. If you or a loved one developed macular edema while using Actos, you may be entitled to file an Actos side effect lawsuit seeking compensation for your injury.

The Actos lawyers at Parker Waichman LLP are investigating the association between Actos and macular edema. If you are a type 2 diabetic who took Actos and suffered vision loss due to macular edema, our Actos lawyers would like to hear from you. Parker Waichman LLP is offering free Actos lawsuit evaluations to anyone who developed macular edema while taking this medication. To protect your legal rights, please contact our Actos lawyers today by calling 1-800-YOURLAWYER (1-800-968-7529) today.

Actos and Macular Edema

Diabetic macular edema occurs when blood vessels in the retina of patients with diabetes begin to leak into the macula, the part of the eye responsible for detailed central vision. These leaks cause the macula to thicken and swell, progressively distorting acute vision. While the swelling may not lead to blindness, the effect can cause a severe loss in central vision. Symptoms of macular edema may include:

• Blurred or wavy central vision
• Colors that appear "washed out" or changed
• Floaters in the field of vision

Small studies and case reports have suggested that thiazolidinediones like Actos may increase the risk of macular edema. However, in June 2012, a study published in the Archives of Internal Medicine found that these drugs could increase the risk for developing the eye disorder by two to three-fold. The study involved over 103,000 people in the U.K. with type 2 diabetes who were followed for about a decade. About 1.3 percent of people taking either Actos or another thiazolidinedione called Avandia developed diabetic macular edema, compared to a rate of 0.2 percent among those who were not on one of the medications.

According to the Archives of Internal Medicine report, the association was seen whether patients were taking Actos or Avandia. The risk increased when thiazolidinedione patients were also using insulin. The authors of the study recommended that patients taking Actos or Avandia have their vision checked regularly, especially if they’re also taking insulin or have a history of visual issues.

Need Legal Help Regarding Actos Macular Edema?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

 

Latest Actos News

September 6, 2011: Parker Waichman LLP files Lawsuit against makers of Diabetes drug Actos alleging Bladder Cancer Link

U.S. Food & Drug Administration (FDA) announces that use of Actos may increase risk of bladder cancer.

GERMANY SUSPENDS DIABETES DRUG ACTOS-Bladder Cancer Link

 

Actos Macular EdemaRSS Feed

North Carolina Man who Developed Bladder Cancer after Taking Actos Files Lawsuit Alleging Actos Caused the Cancer

Sep 28, 2012 | Parker Waichman LLP
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a North Carolina man. The suit was filed on September 17th in the U.S. District Court for the Western District of Louisiana (Case No. 6:12-cv-2490). There, it is one of many similar cases pending in the multidistrict litigation known as In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299)....

National Defective Drug Attorneys Warn that Newly Approved Generic Actos has Similar Risk of Bladder Cancer, Other Side Effects

Aug 21, 2012 | Parker Waichman LLP
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, is warning consumers that generic versions of Actos, like the brand name, carry an increased risk of bladder cancer and other complications. The U.S. Food and Drug Administration (FDA) approved 15 mg, 30 mg and 45 mg doses of generic Actos last week. Generic drugs are therapeutically equivalent to the brand name, but the cost is significantly lower to due to the expired patent....

National Defective Drug Lawyers File Lawsuit on Behalf of Bladder Cancer Patient who Took Takeda's Type 2 Diabetes Drug, Actos

Jul 23, 2012 | Parker Waichman LLP
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a Kentucky woman naming Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co as Defendants. The complaint alleges that the Defendants were negligent and/or fraudulent with regard to Actos, which had a direct negative impact on...

Parker Waichman Files Another Actos Bladder Cancer Lawsuit on Behalf of a Louisiana Man Who Developed Bladder Cancer Allegedly Due to Using the Diabetes Drug Actos

Jul 11, 2012 | Parker Waichman LLP
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co., alleging that their diabetes drug Actos caused bladder cancer in one Louisiana man. The suit was filed on June 14th in the U.S. District Court for the Western District of...

Another Study Ties Actos to Higher Bladder Cancer Risk

Jul 5, 2012 | Parker Waichman LLP
A new study published in the Canadian Medical Association Journal has found that diabetics who use Actos (pioglitazone) face a higher risk of developing bladder cancer.  The publication of the study comes just a little over a years since the Actos label was updated to warn that patients who take the drug long-term may be more likely to develop bladder cancer.Type 2 diabetes already boosts bladder cancer risk by 40%.  This new study involved a meta-analysis of 10 earlier studies of...

More Actos Macular Edema News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo